中华皮肤科杂志 ›› 2011, Vol. 44 ›› Issue (9): 626-628.

• 论著 • 上一篇    下一篇

CD20阳性的非特殊类型性外周T细胞性淋巴瘤一例

鲁严1,张美华1,骆丹2,仇红霞3,4,苏忠兰1,吴迪5,朱丰3,4   

  1. 1. 南京医科大学第一附属医院皮肤科
    2. 南京市南京医科大学附属第一医院皮肤科
    3.
    4. 江苏省人民医院
    5. 南京医科大学第一附属医院
  • 收稿日期:2010-12-02 修回日期:2011-07-12 出版日期:2011-09-15 发布日期:2011-08-31
  • 通讯作者: 鲁严 E-mail:luyan1971@yahoo.com.cn

CD20 positive peripheral T cell lymphoma unspecified: a case report

  • Received:2010-12-02 Revised:2011-07-12 Online:2011-09-15 Published:2011-08-31
  • Contact: Yan Lu E-mail:luyan1971@yahoo.com.cn

摘要:

患者男,81岁。左足背复发性溃疡8年,渐累及双下肢。各系统检查未见异常。皮肤科检查:左足背红肿,约7 cm × 10 cm范围的皮肤溃疡面,基底部可见肌腱,皮损周围皮肤呈紫褐色,边缘堤状隆起;右足内缘可见数个粟米大小丘疹样皮疹,排列呈环状;双下肢散在暗红色及棕色结节或色素沉着斑,压痛。左足背溃疡及右足丘疹样皮疹组织病理检查:HE染色表皮内见明显的亲表皮性浸润,真皮全层中等大小淋巴样细胞浸润,有明显异形性,核分裂象易见;免疫组化CD3(++),CD45RO(+),CD43(++),CD20(++),PAX-5散在阳性,CD79α(-)、CD19(-);TCR-γ基因重排阳性。诊断:CD20阳性的非特殊类型外周T细胞性淋巴瘤。治疗:给予改良CHOP方案化疗,环磷酰胺0.8 g、长春新碱2 mg、表阿霉素60 mg静脉滴注,同时口服泼尼松15 mg每日2次共5 d;每隔21 d为一化疗周期,治疗3个周期后皮损明显好转。

关键词: 淋巴瘤

Abstract:

An 81-year-old male presented with an 8-year history of recurrent ulcer on the left dorsal foot which gradually spread to involve both lower limbs. Physical examination revealed no abnormality of any organ systems and no palpable superficial lymph nodes. Skin examination showed erythematous swelling of the left dorsal foot with an ulcer sized 7 cm × 10 cm on the surface. Tendon was visible at the base of the ulcer, and the ulcer margin was elevated giving a dyke-like appearance. The perilesional skin was purple-brown. There were several millet-like papuloid lesions circularly arranged at the inner side of the right foot as well as dark erythematous or brown nodules and pigmented patches with tenderness on both lower limbs. Histopathology of the ulcer of the left dorsal foot and papuloid lesions on the right foot revealed a visible epidermotropic infiltrate in the epidermis as well as an infiltration throughout the entire dermis with medium-sized atypical lymphoid cells with obvious mitoses. Immunohistochemical examination showed the coexpression of both T cell markers (including CD3, CD45RO, CD43) and B cell marker (CD20), with scatted positive staining for PAX-5 and negative staining for CD79α or CD19. PCR confirmed the rearrangement of T cell receptor (TCR)-γ gene. A diagnosis of peripheral T cell lymphoma unspecified was made in view of the rearrangement of TCR-γ gene and above findings. The patient was treated with the following modified CHOP regimen: intravenous cyclophosphamide 0.8 g, leurocristine 2 mg and epirubicin hydrochloride 60 mg, as well as oral prednisone 15 mg twice daily for 5 days every 3 weeks (one treatment session). After 3 treatment sessions, the lesions improved markedly.

Key words: lymphoma